Docu Liquid

Product NDC: 17856-0771
11-digit product format: 178560771
Labeler code: 17856
Product ID: 17856-0771_3b3f3045-55db-5ed5-e063-6294a90aab75
Type: HUMAN OTC DRUG
Nonproprietary name: Docusate Sodium
Dosage form: LIQUID
Route: ORAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: M
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1997-08-01
Substance: DOCUSATE SODIUM
Active strength: 50 mg/5mL
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	17856-0771	17856-0771-1	D	Discontinued by firm		2026-10-12
excluded package	package	17856-0771	17856-0771-2	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 19 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-2	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-2	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Docu Liquid
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOCUSATE SODIUM	50 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F05Q2T2JA0	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1248119	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f4ed0721-3be9-4108-a6c9-dbbe115249e9	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
17856-0771-1	2024-05-24	Drug Facts
17856-0771-2	2024-05-24	Drug Facts
17856-0771-1	2022-01-28	Drug Facts
17856-0771-2	2022-01-28	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0771-1	Docu Liquid	50 in 1 BOX, UNIT-DOSE	LIQUID	50	3
17856-0771-1	Docu Liquid	25 mL in 1 CUP, UNIT-DOSE	LIQUID	25	3
17856-0771-2	Docu Liquid	10 mL in 1 CUP, UNIT-DOSE	LIQUID	10	3
17856-0771-2	Docu Liquid	72 in 1 BOX, UNIT-DOSE	LIQUID	72	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17856-0771-2	ML - Milliliter	17856-0771	c48e96da-0bd0-41c4-8dbf-13b1c32d8db9	1	2022-09-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0771	DOCU LIQUID (DOCUSATE SODIUM) LIQUID [ATLANTIC BIOLOGICALS CORP.]	2	Current NDC, Legacy NDC, 4 package rows	20240526_f4ed0721-3be9-4108-a6c9-dbbe115249e9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 6 · 111 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MAX relief junior	ACETAMINOPHEN	ATLANTIC BIOLOGICALS CORP.	396903dc-ae2d-4bf4-b1fd-0017b84abef9	2024-02-28	Warnings	Exact identifier application number: M
MAX relief junior	ACETAMINOPHEN	ATLANTIC BIOLOGICALS CORP.	44730cbd-5b98-49bd-b3b8-6fecb0ccd153	2024-02-28	Warnings	Exact identifier application number: M
HYDROCORTISONE	HYDROCORTISONE ACETATE	HART Health	779f945f-ab69-40de-8d86-ab76debc5c7c	2024-02-16	Warnings	Exact identifier application number: M
First Aid and Burn	BENZALKONIUM CHLORIDE, LIDOCAINE	HART Health	f5746bba-9d7f-4691-b466-14985473bf14	2024-02-16	Warnings	Exact identifier application number: M
IBUPROFEN	IBUPROFEN	HART Health	1c1374e1-890f-48ab-8f93-e84da9d5bf84	2024-01-25	Warnings	Exact identifier application number: M
Hand Sanitizer	ANTISEPTIC GEL	HART Health	f07daf29-d0db-4cf8-8baf-d175c2b2ef50	2024-01-25	Warnings	Exact identifier application number: M
Hydrogen Peroxide	HYDROGEN PEROXIDE	HART Health	0346a322-8f6e-405a-8d17-8bc6ce5105a3	2024-01-24	Warnings	Exact identifier application number: M
Alcohol	ISOPROPYL ALCOHOL	NorMed	441b915a-287f-4734-b4d9-730b3d95e04c	2024-01-24	Warnings	Exact identifier application number: M
Sooth-a-Sting	BENZOCAINE	HART Health	bd7229b6-813a-4149-bfe2-fe682f270ff4	2024-01-18	Warnings	Exact identifier application number: M
First Aid	BENZALKONIUM CHLORIDE, BENZOCAINE	HART Health	a6d258ed-6d6d-42f0-9994-6c2c4c3d0f4a	2024-01-18	Warnings	Exact identifier application number: M
TRIBIOTIC	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	HART Health	d8f175f9-f526-4c73-a171-49309ca16cb0	2024-01-18	Warnings, Adverse reactions	Exact identifier application number: M

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1248119	docusate sodium 50 MG in 5 mL Oral Suspension	PSN	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 10 MG/ML Oral Suspension	SCD	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 100 MG per 10 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 150 MG per 15 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 50 MG per 5 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	DOSS Sodium 10 MG/ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-0771-1	17856077101	50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-1) > 25 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current
17856-0771-2	17856077102	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-2) > 10 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current